(19)
(11) EP 1 571 903 A1

(12)

(43) Date of publication:
14.09.2005 Bulletin 2005/37

(21) Application number: 03795884.0

(22) Date of filing: 11.12.2003
(51) International Patent Classification (IPC)7A01K 67/033, C07K 14/435, C12Q 1/68
(86) International application number:
PCT/EP2003/014078
(87) International publication number:
WO 2004/052094 (24.06.2004 Gazette 2004/26)
(84) Designated Contracting States:
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PT RO SE SI SK TR
Designated Extension States:
AL LT LV MK

(30) Priority: 12.12.2002 US 432854 P

(71) Applicants:
  • Novartis AG
    4056 Basel (CH)

    BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PT RO SE SI SK TR 
  • Novartis Pharma GmbH
    1230 Wien (AT)

    AT 

(72) Inventor:
  • LI, Hao
    Warren, NJ 07959 (US)

(74) Representative: de Weerd, Petrus G.W. 
Novartis International AG Corporate Intellectual Property
4002 Basel
4002 Basel (CH)

   


(54) METHOD TO TREAT CONDITIONS ASSOCIATED WITH INSULIN SIGNALING DYSREGULATION